Read more
3:49 PM · 12 November 2021

Johnson & Johnson to split into two companies

-
-
Open account Download free app

Johnson & Johnson (JNJ.US) announced in a statement that it intends to split into two companies, dealing separately with the production and sale of care products, including plasters, soaps and shampoos, and the pharmaceutical and medical segment (including vaccines for COVID). The company plans to complete the entire restructuring process within 18 to 24 months. Currently, the market has reacted positively to the news of the demerger, with shares currently up nearly 1.5%.

 

Alex Gorsky, J&J’s chief executive, said that separation is “the best way to accelerate our efforts to serve patients, consumers, and healthcare professionals, create opportunities for our talented global team, drive profitable growth, and — most importantly — improve healthcare outcomes for people around the world”.

 

The company wants to focus on pharmaceuticals and medical devices, and has decided to spin off an entity focusing on consumer products, most likely through a share offering. The whole transaction is to be tax-free, and the dividend level is to remain unchanged.

 The company's shares opened with a large gap and are now breaking out of the consolidation zone (orange box). For the demand side, the key is to maintain the lower limit of the consolidation zone, near the level of $162 per share. A bottom breakout from this level could lead to a deepening of declines to the area of $157. Source: xStation 5

6 February 2026, 2:09 PM

Kongsberg Gruppen after earnings: The company catches up with the sector

6 February 2026, 1:20 PM

Market wrap: European indices attempt a rebound after Wall Street’s record selloff 🔨

6 February 2026, 6:56 AM

Morning wrap: Tech sector sell-off (06.02.2026)

5 February 2026, 9:38 PM

Amazon shares tumble 10% as investors recoil at the price of AI dominance

Join over 2 000 000 XTB Group Clients from around the world
The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits